Funding for UK-based health tech companies dropped by 37% in 2022, according to new research from market intelligence platform Tracxn.
Funding for the UK health tech sector dropped from $2.11bn in 2021 down to $1.32bn in 2022 in a year when rising interest rates and soaring inflation caused a drawback in overall tech investment levels.
The report, released to coincide with World Health Day, found that the decline was driven by a 58% drop in late-stage funding and a 23% in early-stage funding.
However, seed-stage funding experienced a 39% year-on-year increase, reaching $254m in 2022.
While the sector experienced a considerable drop off in funding last year, 2022 was still the second most well-funded year for British health tech in the past decade.
The majority of the funding activity came in the second half of the year, representing 61% of deals in 2022. This is in direct contrast to the UK tech sector as a whole, which saw funding levels decline towards the end of the year.
Within that half, the third quarter had the most health tech funding activity, contributing 38% of the year’s investment capital.
Notable investment rounds for UK health tech companies last year included a £25m Series B extension for Zoe Health, a nutrition and medical testing app, and a £74m Series C round for Osler Diagnostics, a University of Oxford spinout that has developed a portable diagnostic medical scanner.
Tracxn’s report noted that the UK leads the continent in the health tech industry, both in terms of funding and the number of startups.
The post UK health tech funding drops 37%, report finds appeared first on UKTN | UK Tech News.
